Framing the detection of incipient tuberculosis infection: A qualitative study of political prioritisation

R. James*, G. Theron, F. Cobelens, N. Engel

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective Incipient Tuberculosis (ITB) refers to Mycobacterium tuberculosis infection that is likely to progress to active disease in the absence of treatment, but without clinical signs, symptoms, radiographic or microbiological evidence of disease. Biomarker-based tests to diagnose incipient TB hold promise for better prediction and, through TB preventive therapy, prevention of disease. This study explored current and future framing and prioritisation of ITB. Methods Twenty-two interviews across eight countries were conducted. A modified Shiffman & Smith Framework, containing four categories-Ideas, Issue Characteristics, Actor Power, and Political Contexts-was used to analyse the current landscape and potential for prioritisation of diagnosis and treatment of ITB. Results Latent TB policy implementation has been slow due to technical, logistical and financial challenges, and because it has been framed in a manner non-conducive to gaining political priority. Framing ITB testing as 'early detection' rather than 'prediction', and its management as 'treatment' rather than 'preventive therapy', may help raise its importance in policies, and its acceptance among actors. Conclusion Consensus surrounding the framing of ITB will be crucial for the successful adoption of ITB diagnostics and treatment. When designing ITB tools and policies, it will be important to address challenges that pertain to latent TB policies.
Original languageEnglish
Pages (from-to)445-453
Number of pages9
JournalTropical Medicine & International Health
Volume27
Issue number4
Early online date22 Feb 2022
DOIs
Publication statusPublished - Apr 2022

Keywords

  • global health
  • health policy
  • health priorities
  • latent tuberculosis
  • qualitative methods
  • tuberculosis
  • PREVENTIVE THERAPY
  • COST-EFFECTIVENESS
  • LATENT
  • HEALTH
  • POLICY
  • PRIORITY
  • REFLECTIONS
  • RIFAPENTINE
  • RETHINKING
  • BIOMARKERS

Cite this